Context Therapeutics Inc. Insider Trading
CNTX
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Jun 2025.
Get an email when CNTX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Martin A. Lehr Chief Executive Officer | Bought | 100,000 | $0.70 | 70K | 10% | Form 4 |
| Jun 6, 2025 | Alex C. Levit Chief Legal Officer, Corp. Sec | Bought | 20,000 | $0.58 | 12K | 32% | Form 4 |
| Jun 6, 2025 | Jennifer Lynn Minai-Azary Chief Financial Officer | Bought | 40,010 | $0.64 | 26K | 100% | Form 4 |
- Jun 9, 2025Martin A. LehrChief Executive Officer · bought 100,000 at $0.7070K10% of stake
- Jun 6, 2025Alex C. LevitChief Legal Officer, Corp. Sec · bought 20,000 at $0.5812K32% of stake
- Jun 6, 2025Jennifer Lynn Minai-AzaryChief Financial Officer · bought 40,010 at $0.6426K100% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with CNTX
Spot a number that looks wrong? Check it in CNTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CNTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.